Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
6.09
+0.05 (0.83%)
Apr 30, 2025, 3:00 PM CST
SHA:600351 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 29, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Market Capitalization | 4,263 | 4,385 | 5,215 | 4,528 | 6,992 | 3,835 | Upgrade
|
Market Cap Growth | -15.93% | -15.93% | 15.19% | -35.24% | 82.33% | -14.58% | Upgrade
|
Enterprise Value | 3,709 | 3,952 | 4,911 | 4,520 | 7,195 | 4,184 | Upgrade
|
Last Close Price | 6.09 | 6.09 | 6.74 | 5.70 | 8.69 | 4.72 | Upgrade
|
PE Ratio | 20.21 | 18.07 | 26.13 | 43.26 | 37.37 | 35.71 | Upgrade
|
Forward PE | - | 15.89 | 15.89 | 15.89 | 15.89 | 15.89 | Upgrade
|
PS Ratio | 1.59 | 1.63 | 1.79 | 1.67 | 2.53 | 1.47 | Upgrade
|
PB Ratio | 1.47 | 1.52 | 1.74 | 1.51 | 2.36 | 1.36 | Upgrade
|
P/TBV Ratio | 1.57 | 1.61 | 1.87 | 1.62 | 2.59 | 1.51 | Upgrade
|
P/FCF Ratio | 9.75 | 10.03 | 13.11 | 11.37 | 20.42 | 12.06 | Upgrade
|
P/OCF Ratio | 9.04 | 9.30 | 10.48 | 9.83 | 15.98 | 10.07 | Upgrade
|
PEG Ratio | - | 1.06 | 1.06 | 1.06 | 1.06 | 1.06 | Upgrade
|
EV/Sales Ratio | 1.31 | 1.47 | 1.69 | 1.66 | 2.60 | 1.61 | Upgrade
|
EV/EBITDA Ratio | 7.43 | 8.31 | 11.00 | 13.37 | 19.77 | 14.56 | Upgrade
|
EV/EBIT Ratio | 10.77 | 11.65 | 16.85 | 25.38 | 36.59 | 35.63 | Upgrade
|
EV/FCF Ratio | 8.49 | 9.04 | 12.35 | 11.35 | 21.01 | 13.15 | Upgrade
|
Debt / Equity Ratio | 0.03 | 0.03 | 0.07 | 0.15 | 0.18 | 0.23 | Upgrade
|
Debt / EBITDA Ratio | 0.20 | 0.20 | 0.46 | 1.29 | 1.47 | 2.26 | Upgrade
|
Debt / FCF Ratio | 0.22 | 0.22 | 0.53 | 1.11 | 1.57 | 2.04 | Upgrade
|
Asset Turnover | 0.73 | 0.73 | 0.73 | 0.66 | 0.68 | 0.63 | Upgrade
|
Inventory Turnover | 3.04 | 3.04 | 2.80 | 2.51 | 2.15 | 2.03 | Upgrade
|
Quick Ratio | 1.82 | 1.82 | 1.60 | 1.40 | 1.23 | 1.05 | Upgrade
|
Current Ratio | 2.68 | 2.68 | 2.23 | 1.88 | 1.79 | 1.57 | Upgrade
|
Return on Equity (ROE) | 7.61% | 7.61% | 6.00% | 3.50% | 6.36% | 3.93% | Upgrade
|
Return on Assets (ROA) | 5.73% | 5.73% | 4.56% | 2.71% | 3.04% | 1.76% | Upgrade
|
Return on Capital (ROIC) | 6.84% | 6.84% | 5.48% | 3.20% | 3.53% | 2.06% | Upgrade
|
Return on Capital Employed (ROCE) | 11.40% | 11.40% | 9.50% | 5.80% | 6.40% | 4.00% | Upgrade
|
Earnings Yield | 5.69% | 5.54% | 3.83% | 2.31% | 2.68% | 2.80% | Upgrade
|
FCF Yield | 10.25% | 9.97% | 7.63% | 8.80% | 4.90% | 8.29% | Upgrade
|
Dividend Yield | 2.46% | - | 2.23% | 0.88% | 0.92% | 1.06% | Upgrade
|
Payout Ratio | 46.79% | 46.79% | 25.69% | 77.98% | 32.29% | 46.10% | Upgrade
|
Buyback Yield / Dilution | 5.25% | 5.25% | 0.89% | -0.02% | 0.04% | 0.86% | Upgrade
|
Total Shareholder Return | 7.71% | 5.25% | 3.12% | 0.85% | 0.96% | 1.92% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.